A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

NCT06884098 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolaemia

Interventions

DRUG: AD-228B
DRUG: AD-2284

Sponsor

Addpharma Inc.